Mycolicibacterium brumae is a Safe and Non-Toxic Immunomodulatory Agent for Cancer Treatment

Intravesical Mycobacterium bovis Bacillus Calmette–Guérin (BCG) immunotherapy remains the gold-standard treatment for non-muscle-invasive bladder cancer patients, even though half of the patients develop adverse events to this therapy. On exploring BCG-alternative therapies, Mycolicibacterium brumae...

Descripción completa

Detalles Bibliográficos
Autores principales: Bach-Griera, Marc, Campo-Pérez, Víctor, Barbosa, Sandra, Traserra, Sara, Guallar-Garrido, Sandra, Moya-Andérico, Laura, Herrero-Abadía, Paula, Luquin, Marina, Rabanal, Rosa Maria, Torrents, Eduard, Julián, Esther
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349652/
https://www.ncbi.nlm.nih.gov/pubmed/32344808
http://dx.doi.org/10.3390/vaccines8020198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349652/
https://www.ncbi.nlm.nih.gov/pubmed/32344808
http://dx.doi.org/10.3390/vaccines8020198

Ejemplares similares